Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0745 | 1 | 1 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0176 | 0.053 | 0.1032 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0453 | 0.5137 | 0.4865 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0453 | 0.5137 | 1 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0176 | 0.053 | 0.1032 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0453 | 0.5137 | 1 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0176 | 0.053 | 0.1032 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0745 | 1 | 1 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0176 | 0.053 | 0.1032 |
Echinococcus multilocularis | 0.0601 | 0.7602 | 1 | |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0453 | 0.5137 | 0.6515 |
Brugia malayi | celfurPC protein | 0.0601 | 0.7602 | 0.4795 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0176 | 0.053 | 0.1032 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0277 | 0.2209 | 1 |
Echinococcus granulosus | furin | 0.0745 | 1 | 1 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0468 | 0.5393 | 0.6877 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0468 | 0.5393 | 0.5135 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0324 | 0.2995 | 0.2995 |
Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0.2465 | 0.2043 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0176 | 0.053 | 0.1032 |
Loa Loa (eye worm) | hypothetical protein | 0.0745 | 1 | 1 |
Schistosoma mansoni | subfamily S8B non-peptidase homologue (S08 family) | 0.0176 | 0.053 | 0.053 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.